开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=1088472, encodeId=b70510884e2bd, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088471, encodeId=db4e10884e178, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552743, encodeId=cea6552e4350, content=国人扎堆的杂志都有问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d3b42248, createdName=zztksxy, createdTime=Mon Feb 19 09:06:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541095, encodeId=ff9554109589, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835101, encodeId=cb2c8351010d, content=审稿速度:1.0 经验分享：涵盖现代生物化学和化学，生物物理学和细胞生理学，物理和工程，分子和结构生物学和医学科学的学科 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50165414105, createdName=ms5075507494691300, createdTime=Wed Dec 28 16:38:21 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514246, encodeId=31df514246ea, content=为什么最近的文章在pubmed上查不到了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=547, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.136.85.79, createdTime=Wed Aug 05 09:08:00 CST 2015, time=2015-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513538, encodeId=2c4d5135381e, content=这杂志不是被关了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec731619730, createdName=huanxing, createdTime=Wed Jul 15 15:42:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513489, encodeId=d0c351348977, content=这个杂志有问题吧！ 不知道收多少钱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d0065891, createdName=notcool, createdTime=Tue Jul 14 00:13:00 CST 2015, time=2015-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512953, encodeId=a75f51295338, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：感谢版权友们提供的信息，让我们在等待被接受的过程中能找到些心理安慰。所以我们也很乐意把自己文章的接受经过在此分享。希望后来者有所启发。总体感觉该杂志还是比较好发的，但文章类型比较杂，而且不是开放获取，文章数量有限，。学术编辑与审稿速度较快，整体速度可以维持在2个月.2014-11-17submit. 2014-11-29. pass technic check 2015-01-10.editor envited.2015-01-11with editor. 2015-01-16 under review 2015-02-12decision in process 2015-03-01accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=620, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7561629527, createdName=Davidmd, createdTime=Thu Jun 25 09:14:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512950, encodeId=0deb5129500d, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：请教大家一个问题，Please note that all submissions to cell biochmistry and biophysics must comply with our editorial policies. In particular, please ensure that your manuscript contains any required statements regarding ethical approval and consent from patients/ participants; adheres to any relevant standards of reporting with a completed checklist where appropriate; and contains an Availability of Supporting Data section explaining how the supporting data is available to researchers, including the repository and accession number where appropriate. Manuscripts which do not adhere to our editorial policies may experience delays or be rejected. Further information about our editorial policies can be found at the following links。跪谢后两个咋弄啊？谢谢谢谢！！！！！！！！！！！！！！！！！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=548, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fa51626840, createdName=frogstyle, createdTime=Thu Jun 25 08:35:00 CST 2015, time=2015-06-25, status=1, ipAttribution=)]

2021-12-28 小动量

RUNINGTITLE的撰写方法？

89 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1088472, encodeId=b70510884e2bd, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088471, encodeId=db4e10884e178, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552743, encodeId=cea6552e4350, content=国人扎堆的杂志都有问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d3b42248, createdName=zztksxy, createdTime=Mon Feb 19 09:06:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541095, encodeId=ff9554109589, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835101, encodeId=cb2c8351010d, content=审稿速度:1.0 经验分享：涵盖现代生物化学和化学，生物物理学和细胞生理学，物理和工程，分子和结构生物学和医学科学的学科 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50165414105, createdName=ms5075507494691300, createdTime=Wed Dec 28 16:38:21 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514246, encodeId=31df514246ea, content=为什么最近的文章在pubmed上查不到了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=547, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.136.85.79, createdTime=Wed Aug 05 09:08:00 CST 2015, time=2015-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513538, encodeId=2c4d5135381e, content=这杂志不是被关了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec731619730, createdName=huanxing, createdTime=Wed Jul 15 15:42:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513489, encodeId=d0c351348977, content=这个杂志有问题吧！ 不知道收多少钱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d0065891, createdName=notcool, createdTime=Tue Jul 14 00:13:00 CST 2015, time=2015-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512953, encodeId=a75f51295338, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：感谢版权友们提供的信息，让我们在等待被接受的过程中能找到些心理安慰。所以我们也很乐意把自己文章的接受经过在此分享。希望后来者有所启发。总体感觉该杂志还是比较好发的，但文章类型比较杂，而且不是开放获取，文章数量有限，。学术编辑与审稿速度较快，整体速度可以维持在2个月.2014-11-17submit. 2014-11-29. pass technic check 2015-01-10.editor envited.2015-01-11with editor. 2015-01-16 under review 2015-02-12decision in process 2015-03-01accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=620, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7561629527, createdName=Davidmd, createdTime=Thu Jun 25 09:14:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512950, encodeId=0deb5129500d, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：请教大家一个问题，Please note that all submissions to cell biochmistry and biophysics must comply with our editorial policies. In particular, please ensure that your manuscript contains any required statements regarding ethical approval and consent from patients/ participants; adheres to any relevant standards of reporting with a completed checklist where appropriate; and contains an Availability of Supporting Data section explaining how the supporting data is available to researchers, including the repository and accession number where appropriate. Manuscripts which do not adhere to our editorial policies may experience delays or be rejected. Further information about our editorial policies can be found at the following links。跪谢后两个咋弄啊？谢谢谢谢！！！！！！！！！！！！！！！！！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=548, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fa51626840, createdName=frogstyle, createdTime=Thu Jun 25 08:35:00 CST 2015, time=2015-06-25, status=1, ipAttribution=)]

2021-12-28 MS68862005

RUNNINGTITLE和TITLE的区别？

118 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1088472, encodeId=b70510884e2bd, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088471, encodeId=db4e10884e178, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552743, encodeId=cea6552e4350, content=国人扎堆的杂志都有问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d3b42248, createdName=zztksxy, createdTime=Mon Feb 19 09:06:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541095, encodeId=ff9554109589, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835101, encodeId=cb2c8351010d, content=审稿速度:1.0 经验分享：涵盖现代生物化学和化学，生物物理学和细胞生理学，物理和工程，分子和结构生物学和医学科学的学科 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50165414105, createdName=ms5075507494691300, createdTime=Wed Dec 28 16:38:21 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514246, encodeId=31df514246ea, content=为什么最近的文章在pubmed上查不到了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=547, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.136.85.79, createdTime=Wed Aug 05 09:08:00 CST 2015, time=2015-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513538, encodeId=2c4d5135381e, content=这杂志不是被关了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec731619730, createdName=huanxing, createdTime=Wed Jul 15 15:42:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513489, encodeId=d0c351348977, content=这个杂志有问题吧！ 不知道收多少钱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d0065891, createdName=notcool, createdTime=Tue Jul 14 00:13:00 CST 2015, time=2015-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512953, encodeId=a75f51295338, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：感谢版权友们提供的信息，让我们在等待被接受的过程中能找到些心理安慰。所以我们也很乐意把自己文章的接受经过在此分享。希望后来者有所启发。总体感觉该杂志还是比较好发的，但文章类型比较杂，而且不是开放获取，文章数量有限，。学术编辑与审稿速度较快，整体速度可以维持在2个月.2014-11-17submit. 2014-11-29. pass technic check 2015-01-10.editor envited.2015-01-11with editor. 2015-01-16 under review 2015-02-12decision in process 2015-03-01accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=620, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7561629527, createdName=Davidmd, createdTime=Thu Jun 25 09:14:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512950, encodeId=0deb5129500d, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：请教大家一个问题，Please note that all submissions to cell biochmistry and biophysics must comply with our editorial policies. In particular, please ensure that your manuscript contains any required statements regarding ethical approval and consent from patients/ participants; adheres to any relevant standards of reporting with a completed checklist where appropriate; and contains an Availability of Supporting Data section explaining how the supporting data is available to researchers, including the repository and accession number where appropriate. Manuscripts which do not adhere to our editorial policies may experience delays or be rejected. Further information about our editorial policies can be found at the following links。跪谢后两个咋弄啊？谢谢谢谢！！！！！！！！！！！！！！！！！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=548, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fa51626840, createdName=frogstyle, createdTime=Thu Jun 25 08:35:00 CST 2015, time=2015-06-25, status=1, ipAttribution=)]

2018-02-19 zztksxy

国人扎堆的杂志都有问题

415 0

[GetPortalCommentsPageByObjectIdResponse(id=1088472, encodeId=b70510884e2bd, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088471, encodeId=db4e10884e178, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552743, encodeId=cea6552e4350, content=国人扎堆的杂志都有问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d3b42248, createdName=zztksxy, createdTime=Mon Feb 19 09:06:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541095, encodeId=ff9554109589, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835101, encodeId=cb2c8351010d, content=审稿速度:1.0 经验分享：涵盖现代生物化学和化学，生物物理学和细胞生理学，物理和工程，分子和结构生物学和医学科学的学科 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50165414105, createdName=ms5075507494691300, createdTime=Wed Dec 28 16:38:21 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514246, encodeId=31df514246ea, content=为什么最近的文章在pubmed上查不到了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=547, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.136.85.79, createdTime=Wed Aug 05 09:08:00 CST 2015, time=2015-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513538, encodeId=2c4d5135381e, content=这杂志不是被关了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec731619730, createdName=huanxing, createdTime=Wed Jul 15 15:42:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513489, encodeId=d0c351348977, content=这个杂志有问题吧！ 不知道收多少钱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d0065891, createdName=notcool, createdTime=Tue Jul 14 00:13:00 CST 2015, time=2015-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512953, encodeId=a75f51295338, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：感谢版权友们提供的信息，让我们在等待被接受的过程中能找到些心理安慰。所以我们也很乐意把自己文章的接受经过在此分享。希望后来者有所启发。总体感觉该杂志还是比较好发的，但文章类型比较杂，而且不是开放获取，文章数量有限，。学术编辑与审稿速度较快，整体速度可以维持在2个月.2014-11-17submit. 2014-11-29. pass technic check 2015-01-10.editor envited.2015-01-11with editor. 2015-01-16 under review 2015-02-12decision in process 2015-03-01accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=620, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7561629527, createdName=Davidmd, createdTime=Thu Jun 25 09:14:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512950, encodeId=0deb5129500d, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：请教大家一个问题，Please note that all submissions to cell biochmistry and biophysics must comply with our editorial policies. In particular, please ensure that your manuscript contains any required statements regarding ethical approval and consent from patients/ participants; adheres to any relevant standards of reporting with a completed checklist where appropriate; and contains an Availability of Supporting Data section explaining how the supporting data is available to researchers, including the repository and accession number where appropriate. Manuscripts which do not adhere to our editorial policies may experience delays or be rejected. Further information about our editorial policies can be found at the following links。跪谢后两个咋弄啊？谢谢谢谢！！！！！！！！！！！！！！！！！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=548, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fa51626840, createdName=frogstyle, createdTime=Thu Jun 25 08:35:00 CST 2015, time=2015-06-25, status=1, ipAttribution=)]

2017-07-14 yumi_123

有点惨淡，这1.5分都保不住，日子怎么过？？

428 0

[GetPortalCommentsPageByObjectIdResponse(id=1088472, encodeId=b70510884e2bd, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088471, encodeId=db4e10884e178, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552743, encodeId=cea6552e4350, content=国人扎堆的杂志都有问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d3b42248, createdName=zztksxy, createdTime=Mon Feb 19 09:06:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541095, encodeId=ff9554109589, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835101, encodeId=cb2c8351010d, content=审稿速度:1.0 经验分享：涵盖现代生物化学和化学，生物物理学和细胞生理学，物理和工程，分子和结构生物学和医学科学的学科 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50165414105, createdName=ms5075507494691300, createdTime=Wed Dec 28 16:38:21 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514246, encodeId=31df514246ea, content=为什么最近的文章在pubmed上查不到了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=547, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.136.85.79, createdTime=Wed Aug 05 09:08:00 CST 2015, time=2015-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513538, encodeId=2c4d5135381e, content=这杂志不是被关了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec731619730, createdName=huanxing, createdTime=Wed Jul 15 15:42:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513489, encodeId=d0c351348977, content=这个杂志有问题吧！ 不知道收多少钱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d0065891, createdName=notcool, createdTime=Tue Jul 14 00:13:00 CST 2015, time=2015-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512953, encodeId=a75f51295338, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：感谢版权友们提供的信息，让我们在等待被接受的过程中能找到些心理安慰。所以我们也很乐意把自己文章的接受经过在此分享。希望后来者有所启发。总体感觉该杂志还是比较好发的，但文章类型比较杂，而且不是开放获取，文章数量有限，。学术编辑与审稿速度较快，整体速度可以维持在2个月.2014-11-17submit. 2014-11-29. pass technic check 2015-01-10.editor envited.2015-01-11with editor. 2015-01-16 under review 2015-02-12decision in process 2015-03-01accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=620, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7561629527, createdName=Davidmd, createdTime=Thu Jun 25 09:14:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512950, encodeId=0deb5129500d, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：请教大家一个问题，Please note that all submissions to cell biochmistry and biophysics must comply with our editorial policies. In particular, please ensure that your manuscript contains any required statements regarding ethical approval and consent from patients/ participants; adheres to any relevant standards of reporting with a completed checklist where appropriate; and contains an Availability of Supporting Data section explaining how the supporting data is available to researchers, including the repository and accession number where appropriate. Manuscripts which do not adhere to our editorial policies may experience delays or be rejected. Further information about our editorial policies can be found at the following links。跪谢后两个咋弄啊？谢谢谢谢！！！！！！！！！！！！！！！！！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=548, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fa51626840, createdName=frogstyle, createdTime=Thu Jun 25 08:35:00 CST 2015, time=2015-06-25, status=1, ipAttribution=)]

2016-12-28 ms5075507494691300

审稿速度:1.0
经验分享：涵盖现代生物化学和化学，生物物理学和细胞生理学，物理和工程，分子和结构生物学和医学科学的学科

189 0

[GetPortalCommentsPageByObjectIdResponse(id=1088472, encodeId=b70510884e2bd, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088471, encodeId=db4e10884e178, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552743, encodeId=cea6552e4350, content=国人扎堆的杂志都有问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d3b42248, createdName=zztksxy, createdTime=Mon Feb 19 09:06:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541095, encodeId=ff9554109589, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835101, encodeId=cb2c8351010d, content=审稿速度:1.0 经验分享：涵盖现代生物化学和化学，生物物理学和细胞生理学，物理和工程，分子和结构生物学和医学科学的学科 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50165414105, createdName=ms5075507494691300, createdTime=Wed Dec 28 16:38:21 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514246, encodeId=31df514246ea, content=为什么最近的文章在pubmed上查不到了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=547, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.136.85.79, createdTime=Wed Aug 05 09:08:00 CST 2015, time=2015-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513538, encodeId=2c4d5135381e, content=这杂志不是被关了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec731619730, createdName=huanxing, createdTime=Wed Jul 15 15:42:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513489, encodeId=d0c351348977, content=这个杂志有问题吧！ 不知道收多少钱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d0065891, createdName=notcool, createdTime=Tue Jul 14 00:13:00 CST 2015, time=2015-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512953, encodeId=a75f51295338, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：感谢版权友们提供的信息，让我们在等待被接受的过程中能找到些心理安慰。所以我们也很乐意把自己文章的接受经过在此分享。希望后来者有所启发。总体感觉该杂志还是比较好发的，但文章类型比较杂，而且不是开放获取，文章数量有限，。学术编辑与审稿速度较快，整体速度可以维持在2个月.2014-11-17submit. 2014-11-29. pass technic check 2015-01-10.editor envited.2015-01-11with editor. 2015-01-16 under review 2015-02-12decision in process 2015-03-01accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=620, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7561629527, createdName=Davidmd, createdTime=Thu Jun 25 09:14:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512950, encodeId=0deb5129500d, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：请教大家一个问题，Please note that all submissions to cell biochmistry and biophysics must comply with our editorial policies. In particular, please ensure that your manuscript contains any required statements regarding ethical approval and consent from patients/ participants; adheres to any relevant standards of reporting with a completed checklist where appropriate; and contains an Availability of Supporting Data section explaining how the supporting data is available to researchers, including the repository and accession number where appropriate. Manuscripts which do not adhere to our editorial policies may experience delays or be rejected. Further information about our editorial policies can be found at the following links。跪谢后两个咋弄啊？谢谢谢谢！！！！！！！！！！！！！！！！！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=548, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fa51626840, createdName=frogstyle, createdTime=Thu Jun 25 08:35:00 CST 2015, time=2015-06-25, status=1, ipAttribution=)]

2015-08-05 117.136.85.79

为什么最近的文章在pubmed上查不到了？

547 0

[GetPortalCommentsPageByObjectIdResponse(id=1088472, encodeId=b70510884e2bd, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088471, encodeId=db4e10884e178, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552743, encodeId=cea6552e4350, content=国人扎堆的杂志都有问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d3b42248, createdName=zztksxy, createdTime=Mon Feb 19 09:06:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541095, encodeId=ff9554109589, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835101, encodeId=cb2c8351010d, content=审稿速度:1.0 经验分享：涵盖现代生物化学和化学，生物物理学和细胞生理学，物理和工程，分子和结构生物学和医学科学的学科 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50165414105, createdName=ms5075507494691300, createdTime=Wed Dec 28 16:38:21 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514246, encodeId=31df514246ea, content=为什么最近的文章在pubmed上查不到了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=547, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.136.85.79, createdTime=Wed Aug 05 09:08:00 CST 2015, time=2015-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513538, encodeId=2c4d5135381e, content=这杂志不是被关了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec731619730, createdName=huanxing, createdTime=Wed Jul 15 15:42:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513489, encodeId=d0c351348977, content=这个杂志有问题吧！ 不知道收多少钱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d0065891, createdName=notcool, createdTime=Tue Jul 14 00:13:00 CST 2015, time=2015-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512953, encodeId=a75f51295338, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：感谢版权友们提供的信息，让我们在等待被接受的过程中能找到些心理安慰。所以我们也很乐意把自己文章的接受经过在此分享。希望后来者有所启发。总体感觉该杂志还是比较好发的，但文章类型比较杂，而且不是开放获取，文章数量有限，。学术编辑与审稿速度较快，整体速度可以维持在2个月.2014-11-17submit. 2014-11-29. pass technic check 2015-01-10.editor envited.2015-01-11with editor. 2015-01-16 under review 2015-02-12decision in process 2015-03-01accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=620, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7561629527, createdName=Davidmd, createdTime=Thu Jun 25 09:14:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512950, encodeId=0deb5129500d, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：请教大家一个问题，Please note that all submissions to cell biochmistry and biophysics must comply with our editorial policies. In particular, please ensure that your manuscript contains any required statements regarding ethical approval and consent from patients/ participants; adheres to any relevant standards of reporting with a completed checklist where appropriate; and contains an Availability of Supporting Data section explaining how the supporting data is available to researchers, including the repository and accession number where appropriate. Manuscripts which do not adhere to our editorial policies may experience delays or be rejected. Further information about our editorial policies can be found at the following links。跪谢后两个咋弄啊？谢谢谢谢！！！！！！！！！！！！！！！！！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=548, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fa51626840, createdName=frogstyle, createdTime=Thu Jun 25 08:35:00 CST 2015, time=2015-06-25, status=1, ipAttribution=)]

2015-07-15 huanxing

这杂志不是被关了吗？

532 0

[GetPortalCommentsPageByObjectIdResponse(id=1088472, encodeId=b70510884e2bd, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088471, encodeId=db4e10884e178, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552743, encodeId=cea6552e4350, content=国人扎堆的杂志都有问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d3b42248, createdName=zztksxy, createdTime=Mon Feb 19 09:06:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541095, encodeId=ff9554109589, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835101, encodeId=cb2c8351010d, content=审稿速度:1.0 经验分享：涵盖现代生物化学和化学，生物物理学和细胞生理学，物理和工程，分子和结构生物学和医学科学的学科 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50165414105, createdName=ms5075507494691300, createdTime=Wed Dec 28 16:38:21 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514246, encodeId=31df514246ea, content=为什么最近的文章在pubmed上查不到了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=547, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.136.85.79, createdTime=Wed Aug 05 09:08:00 CST 2015, time=2015-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513538, encodeId=2c4d5135381e, content=这杂志不是被关了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec731619730, createdName=huanxing, createdTime=Wed Jul 15 15:42:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513489, encodeId=d0c351348977, content=这个杂志有问题吧！ 不知道收多少钱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d0065891, createdName=notcool, createdTime=Tue Jul 14 00:13:00 CST 2015, time=2015-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512953, encodeId=a75f51295338, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：感谢版权友们提供的信息，让我们在等待被接受的过程中能找到些心理安慰。所以我们也很乐意把自己文章的接受经过在此分享。希望后来者有所启发。总体感觉该杂志还是比较好发的，但文章类型比较杂，而且不是开放获取，文章数量有限，。学术编辑与审稿速度较快，整体速度可以维持在2个月.2014-11-17submit. 2014-11-29. pass technic check 2015-01-10.editor envited.2015-01-11with editor. 2015-01-16 under review 2015-02-12decision in process 2015-03-01accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=620, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7561629527, createdName=Davidmd, createdTime=Thu Jun 25 09:14:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512950, encodeId=0deb5129500d, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：请教大家一个问题，Please note that all submissions to cell biochmistry and biophysics must comply with our editorial policies. In particular, please ensure that your manuscript contains any required statements regarding ethical approval and consent from patients/ participants; adheres to any relevant standards of reporting with a completed checklist where appropriate; and contains an Availability of Supporting Data section explaining how the supporting data is available to researchers, including the repository and accession number where appropriate. Manuscripts which do not adhere to our editorial policies may experience delays or be rejected. Further information about our editorial policies can be found at the following links。跪谢后两个咋弄啊？谢谢谢谢！！！！！！！！！！！！！！！！！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=548, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fa51626840, createdName=frogstyle, createdTime=Thu Jun 25 08:35:00 CST 2015, time=2015-06-25, status=1, ipAttribution=)]

2015-07-14 notcool

这个杂志有问题吧！
不知道收多少钱

491 0

[GetPortalCommentsPageByObjectIdResponse(id=1088472, encodeId=b70510884e2bd, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088471, encodeId=db4e10884e178, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552743, encodeId=cea6552e4350, content=国人扎堆的杂志都有问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d3b42248, createdName=zztksxy, createdTime=Mon Feb 19 09:06:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541095, encodeId=ff9554109589, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835101, encodeId=cb2c8351010d, content=审稿速度:1.0 经验分享：涵盖现代生物化学和化学，生物物理学和细胞生理学，物理和工程，分子和结构生物学和医学科学的学科 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50165414105, createdName=ms5075507494691300, createdTime=Wed Dec 28 16:38:21 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514246, encodeId=31df514246ea, content=为什么最近的文章在pubmed上查不到了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=547, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.136.85.79, createdTime=Wed Aug 05 09:08:00 CST 2015, time=2015-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513538, encodeId=2c4d5135381e, content=这杂志不是被关了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec731619730, createdName=huanxing, createdTime=Wed Jul 15 15:42:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513489, encodeId=d0c351348977, content=这个杂志有问题吧！ 不知道收多少钱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d0065891, createdName=notcool, createdTime=Tue Jul 14 00:13:00 CST 2015, time=2015-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512953, encodeId=a75f51295338, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：感谢版权友们提供的信息，让我们在等待被接受的过程中能找到些心理安慰。所以我们也很乐意把自己文章的接受经过在此分享。希望后来者有所启发。总体感觉该杂志还是比较好发的，但文章类型比较杂，而且不是开放获取，文章数量有限，。学术编辑与审稿速度较快，整体速度可以维持在2个月.2014-11-17submit. 2014-11-29. pass technic check 2015-01-10.editor envited.2015-01-11with editor. 2015-01-16 under review 2015-02-12decision in process 2015-03-01accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=620, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7561629527, createdName=Davidmd, createdTime=Thu Jun 25 09:14:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512950, encodeId=0deb5129500d, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：请教大家一个问题，Please note that all submissions to cell biochmistry and biophysics must comply with our editorial policies. In particular, please ensure that your manuscript contains any required statements regarding ethical approval and consent from patients/ participants; adheres to any relevant standards of reporting with a completed checklist where appropriate; and contains an Availability of Supporting Data section explaining how the supporting data is available to researchers, including the repository and accession number where appropriate. Manuscripts which do not adhere to our editorial policies may experience delays or be rejected. Further information about our editorial policies can be found at the following links。跪谢后两个咋弄啊？谢谢谢谢！！！！！！！！！！！！！！！！！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=548, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fa51626840, createdName=frogstyle, createdTime=Thu Jun 25 08:35:00 CST 2015, time=2015-06-25, status=1, ipAttribution=)]

2015-06-25 Davidmd

审稿速度:6.0 | 投稿命中率:75.0
经验分享：感谢版权友们提供的信息，让我们在等待被接受的过程中能找到些心理安慰。所以我们也很乐意把自己文章的接受经过在此分享。希望后来者有所启发。总体感觉该杂志还是比较好发的，但文章类型比较杂，而且不是开放获取，文章数量有限，。学术编辑与审稿速度较快，整体速度可以维持在2个月.2014-11-17submit. 2014-11-29. pass technic check 2015-01-10.editor envited.2015-01-11with editor. 2015-01-16 under review 2015-02-12decision in process 2015-03-01accept

620 0

[GetPortalCommentsPageByObjectIdResponse(id=1088472, encodeId=b70510884e2bd, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088471, encodeId=db4e10884e178, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552743, encodeId=cea6552e4350, content=国人扎堆的杂志都有问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d3b42248, createdName=zztksxy, createdTime=Mon Feb 19 09:06:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541095, encodeId=ff9554109589, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835101, encodeId=cb2c8351010d, content=审稿速度:1.0 经验分享：涵盖现代生物化学和化学，生物物理学和细胞生理学，物理和工程，分子和结构生物学和医学科学的学科 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50165414105, createdName=ms5075507494691300, createdTime=Wed Dec 28 16:38:21 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514246, encodeId=31df514246ea, content=为什么最近的文章在pubmed上查不到了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=547, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.136.85.79, createdTime=Wed Aug 05 09:08:00 CST 2015, time=2015-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513538, encodeId=2c4d5135381e, content=这杂志不是被关了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec731619730, createdName=huanxing, createdTime=Wed Jul 15 15:42:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513489, encodeId=d0c351348977, content=这个杂志有问题吧！ 不知道收多少钱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d0065891, createdName=notcool, createdTime=Tue Jul 14 00:13:00 CST 2015, time=2015-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512953, encodeId=a75f51295338, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：感谢版权友们提供的信息，让我们在等待被接受的过程中能找到些心理安慰。所以我们也很乐意把自己文章的接受经过在此分享。希望后来者有所启发。总体感觉该杂志还是比较好发的，但文章类型比较杂，而且不是开放获取，文章数量有限，。学术编辑与审稿速度较快，整体速度可以维持在2个月.2014-11-17submit. 2014-11-29. pass technic check 2015-01-10.editor envited.2015-01-11with editor. 2015-01-16 under review 2015-02-12decision in process 2015-03-01accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=620, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7561629527, createdName=Davidmd, createdTime=Thu Jun 25 09:14:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512950, encodeId=0deb5129500d, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：请教大家一个问题，Please note that all submissions to cell biochmistry and biophysics must comply with our editorial policies. In particular, please ensure that your manuscript contains any required statements regarding ethical approval and consent from patients/ participants; adheres to any relevant standards of reporting with a completed checklist where appropriate; and contains an Availability of Supporting Data section explaining how the supporting data is available to researchers, including the repository and accession number where appropriate. Manuscripts which do not adhere to our editorial policies may experience delays or be rejected. Further information about our editorial policies can be found at the following links。跪谢后两个咋弄啊？谢谢谢谢！！！！！！！！！！！！！！！！！！！！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=548, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fa51626840, createdName=frogstyle, createdTime=Thu Jun 25 08:35:00 CST 2015, time=2015-06-25, status=1, ipAttribution=)]

2015-06-25 frogstyle

审稿速度:12.0 | 投稿命中率:50.0
经验分享：请教大家一个问题，Please note that all submissions to cell biochmistry and biophysics must comply with our editorial policies. In particular, please ensure that your manuscript contains any required statements regarding ethical approval and consent from patients/ participants; adheres to any relevant standards of reporting with a completed checklist where appropriate; and contains an Availability of Supporting Data section explaining how the supporting data is available to researchers, including the repository and accession number where appropriate. Manuscripts which do not adhere to our editorial policies may experience delays or be rejected. Further information about our editorial policies can be found at the following links。跪谢后两个咋弄啊？谢谢谢谢！！！！！！！！！！！！！！！！！！！！！！！

548 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务